reference/1007552

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1007552

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	145
issn	1097-0142 0008-543X
issueIdentifier	1
pageRange	136-145
publicationName	Cancer
startingPage	136
bibliographicCitation	Schmitz N, Kloess M, Reiser M, Berdel WE, Metzner B, Dorken B, Kneba M, Trumper L, Loeffler M, Pfreundschuh M, Glass B; German High-Grade Non Hodgkin's Lymphoma Study Group (DSHNHL). Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma. Cancer. 2006 Jan 01;106(1):136–45. doi: 10.1002/cncr.21588. PMID: 16331635.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec45e727df613e87a14ac1fa98b06f7b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_879ac75affd73e0012dcd6f949288c20 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_586a9a07a20cc5d12a0300222127b690 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4724bcf07d49cd3a80c65d3805c9f8bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3e9ab0da0a1cb7ad207b682675718d07 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_017c97b2236bebb6fa43ab7bff5005bc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_517e965c836bc10a9b1346765d9a06be http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_430ae2608e4332617b39f2462aff2d6a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93d61f964a8440bf6317c0c414d64e58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe13a9db51ddcc88c821b6f5ba174ee6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_640bb5453b94fbbf3f81a15a5fd21dce
date	2005-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/16331635 https://doi.org/10.1002/cncr.21588
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2771 https://portal.issn.org/resource/ISSN/1097-0142 https://portal.issn.org/resource/ISSN/0008-543X
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Four versus six courses of a dose-escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation: early dose intensity is crucial in treating younger patients with poor prognosis aggressive lymphoma
discusses	http://id.nlm.nih.gov/mesh/M0005485 http://id.nlm.nih.gov/mesh/M0017465 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0022676 http://id.nlm.nih.gov/mesh/M0028322 http://id.nlm.nih.gov/mesh/M0007930
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D036102 http://id.nlm.nih.gov/mesh/D008223Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005047Q000008 http://id.nlm.nih.gov/mesh/D000971Q000009 http://id.nlm.nih.gov/mesh/D000971Q000008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D018952Q000276 http://id.nlm.nih.gov/mesh/D011241Q000008 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D003131 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D008223Q000401 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D014750Q000008 http://id.nlm.nih.gov/mesh/D003520Q000008 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D014182
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134755071 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5388993 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62313 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8388 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164145 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45358158 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6324671 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3717450 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296921 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717275 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128334455

Total number of triples: 76.